Related Experiment Video
Updated: Jul 13, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
[Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function]
Xiao-Ping Guo1, Yan-Fei Chen1, Ping Chen1
1Division/Center of Pediatric Hematology-Oncology, Children's Hospital, Zhejiang University School of Medicine, The Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China.
Human bone marrow mesenchymal stem cells (MSCs) with high OCT4 expression effectively inhibit T-cell proliferation and activation. These MSC-OCT4 cells demonstrate enhanced proliferation and sustained immunosuppressive potential in vitro.
Area of Science:
- Immunology
- Stem Cell Biology
- Cellular Biology
Context:
- Mesenchymal stem cells (MSCs) are known for their immunomodulatory properties.
- The transcription factor OCT4 plays a crucial role in stem cell pluripotency and differentiation.
- Understanding the interplay between MSCs, OCT4, and T-cell responses is vital for regenerative medicine and immunotherapy.
Purpose:
- To investigate the impact of ectopic high OCT4 expression in human bone marrow MSCs on T-cell proliferation, activation, and cytokine secretion in vitro.
- To compare the immunomodulatory effects of MSCs with and without OCT4 overexpression on activated T lymphocytes.
Summary:
- Co-culture of activated T lymphocytes with MSCs and MSCs overexpressing OCT4 (MSC-OCT4) demonstrated significant inhibition of T-cell proliferation (CD3+, CD4+, CD8+).
- MSC-OCT4 exhibited superior inhibition of CD3+CD8+ T-cell proliferation and early T-cell activation compared to MSCs alone.
- Both cell types downregulated IL-2 and IFN-γ, while IL-6 levels increased post-co-culture. MSC-OCT4 showed enhanced in vitro proliferation and resistance to mitomycin C-induced inhibition.
Impact:
- Ectopic OCT4 expression enhances the in vitro proliferation and immunosuppressive capacity of human bone marrow MSCs.
- MSC-OCT4 demonstrates a more potent and potentially longer-lasting inhibition of T-cell activation, particularly CD8+ T cells.
- These findings suggest that MSC-OCT4 could be a promising candidate for therapeutic applications requiring robust immunomodulation and regulation of T-cell responses.
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells

